medigraphic.com
SPANISH

Revista de Endocrinología y Nutrición

ISSN 0188-9796 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2004, Number 2

<< Back Next >>

Rev Endocrinol Nutr 2004; 12 (2)

Bone mass density in a postmenopausal women sample of north of Mexico

Zúñiga-González S, Galindo-Enríquez E, Pérez-Rodríguez P
Full text How to cite this article

Language: Spanish
References: 11
Page: 69-72
PDF size: 64.87 Kb.


Key words:

Osteoporosis, osteopenia, postmenopausal, prevention.

ABSTRACT

Objective: To analyze the bone mass density in a north Mexico postmenopausal women group. Material and methods: We evaluated a 410 Mexican women group, 55-85 years old, with dual-energy X-ray absorptiometry in femur, spine or total body. Results: The analysis with SPSS statistic program shows 32% osteoporosis, 49% osteopenia, and normal bone mass density (BMD) in 19% of patients. The mean age in normal bone density was 65 ± 4.8 years, in osteopenia was 67 ± 6.1 years, and osteoporosis 70 ± 7.9 years, with groups variance of 6.845 (p = .001). In the 84 patients with fracture in diverse sites, we found normal BMD in 8 (9.5%), osteopenia in 43 (51.2%) and osteoporosis in 33 patients (39.3%). In asymptomatic women studied like part of preventive actions (40%), found osteoporosis in 26%, osteopenia 54%, and normal BMD in 20% of patients. Conclusion: In our study we found approximately one of three women older than 55 years presented osteoporosis, and near 1 of two, osteopenia. The bone mass density evaluation is very important in women of 55 years old or more for early diagnosis and treatment.


REFERENCES

  1. WHO: Osteoporosis. Switzerland World Health Organization, 1999.

  2. The WHO Study Group: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Switzerland World Health Organization, 1994.

  3. Kanis JA. Osteoporosis. Blackwell Science Ltd. Londres 1994.

  4. Melton LJ. Epidemiology of fractures. In: Osteoporosis: etiology, diagnosis and management. Riggs BL, Melton LJ III (Eds.). Raven Press New York, 1988: 133-154.

  5. Looker AC, Johnston CC Jr, Wahner HW et al. Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res 1995; 10: 796-802.

  6. Delezé M, Aguirre E, Villa A et al. The prevalence of osteoporosis and osteopenia by DEXA in an apparently healthy Mexican population. A multicenter study. Arthritis Rheum 1997; (suppl)40: 9-41.

  7. Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KL. Epidemiology of osteoporosis and osteoporosis fractures. Epidemiol Rev 1985; 7: 178-208.

  8. Riggs BL, Melton LJ. The worldwide problem of osteoporosis. Insights afforded by epidemiology. Bone 1995; 17: 505S-511S.

  9. Cummings SR, Black DM, Rubin SM. Lifetime risk of hip, Colles or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med 1989; 149: 2445-2448.

  10. Murrillo-Uribe A, Deleze-Hinojosa M, Aguirre E, Villa A, Calva J, Cons F, Briseño A, González G, Morales J, Pena H, Guerrero G, Orozco J, Morales G, Elizondo J. Osteoporosis en la mujer postmenopáusica mexicana. Magnitud del problema. Estudio multicéntrico. Ginecol Obstet Mex 1999; 67: 227-233.

  11. McGarry KA, Tammaro D, Cyr MG. Diagnosing and managing postmenopausal osteoporosis: opportunities for fracture prevention. Compr Ther 2003; 29(2-3): 115-123.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Endocrinol Nutr. 2004;12